Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

314 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

NCT00323804

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations
  • CHU Brugmann Brussels, Belgium
  • Hôpital Bracops Brussels, Belgium
  • Hôpital Erasme Brussels, Belgium
  • Hôpital de Jolimont La Louvière, Belgium
View all 45 locations
View Trial Details
Completed

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

NCT01329978

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Alabama Liver and Digestive Specialist Montgomery, Alabama, United States
  • Clopton Clinic Jonesboro, Arkansas, United States
  • Advanced Clinical Research Institute Anaheim, California, United States
  • Providence Clinical Research Burbank, California, United States
View all 46 locations
View Trial Details
Completed

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

NCT01371578

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Alabama Liver and Digestive Specialists Montgomery, Alabama, United States
  • California Liver Institute Beverly Hills, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 55 locations
View Trial Details
Completed

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

NCT01435044

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +25 more
Locations
  • Alabama Liver & Digestive Specialists Montgomery, Alabama, United States
  • Bakersfield, California, United States
  • Coronado, California, United States
  • La Mesa, California, United States
View all 44 locations
View Trial Details
Completed

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

NCT01271790

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Alabama Liver and Digestive Specialists Montgomery, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 144 locations
View Trial Details

Related conditions